» Articles » PMID: 8600510

Comparing Techniques of Measuring Tumor Hypoxia in Different Murine Tumors: Eppendorf PO2 Histograph, [3H]misonidazole Binding and Paired Survival Assay

Overview
Journal Radiat Res
Specialties Genetics
Radiology
Date 1996 Apr 1
PMID 8600510
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Using five transplantable murine tumors (SCC-VII, B16F1, KHT-C, KHT-LP1, RIF-1), measurements of tumor hypoxia have been made with two techniques which have the potential to be used for assessing oxygenation in human tumors (the Eppendorf pO2 Histograph and binding of [3H]misonidazole) and have been compared with an established radiobiological technique, the paired survival assay. There were significant differences in the pO2 measurements made in individual tumors both within and between the five different tumor types. Significant differences between the tumor types were also found for the [3H]misonidazole binding. A correlation was observed between the mean values of the hypoxic proportion as measured by the paired survival assay and the mean binding of [3H]misonidazole as measured by both tumor activity in dpm/100 mg tissue (r = 0.94, P = 0.02) and the tumor-to-muscle activity ratio (r = 0.87, P = 0.06). No biologically significant correlation was seen between the mean values of the hypoxic proportion from anesthetized mice as measured by the paired survival assay (range 20-58%) and the pooled Eppendorf pO2 Histograph measurements made on groups of tumors. These results with the Eppendorf pO2 Histograph are similar to those reported by others. When both Eppendorf pO2 Histograph measurements and paired survival measurements were made on the same individual KHT-C tumors, it was again found that there was no correlation between the two measurements of hypoxia.

Citing Articles

Neon ion ( Ne ) charged particle beams manipulate rapid tumor reoxygenation in syngeneic mouse models.

Imaizumi A, Hirayama R, Ikoma Y, Nitta N, Obata T, Hasegawa S Cancer Sci. 2023; 115(1):227-236.

PMID: 37994570 PMC: 10823265. DOI: 10.1111/cas.16017.


FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response.

Velalopoulou A, Karagounis I, Cramer G, Kim M, Skoufos G, Goia D Cancer Res. 2021; 81(18):4808-4821.

PMID: 34321243 PMC: 8715480. DOI: 10.1158/0008-5472.CAN-21-1500.


Temporal variation in the response of tumors to hyperoxia with breathing carbogen and oxygen.

Hou H, Khan N, Du G, Hodge S, Swartz H Med Gas Res. 2016; 6(3):138-146.

PMID: 27867481 PMC: 5110141. DOI: 10.4103/2045-9912.191359.


(18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.

Toyonaga T, Hirata K, Yamaguchi S, Hatanaka K, Yuzawa S, Manabe O Eur J Nucl Med Mol Imaging. 2016; 43(8):1469-76.

PMID: 26841941 DOI: 10.1007/s00259-016-3320-x.


Blood oxygen level dependent magnetization transfer (BOLDMT) effect.

Cai K, Haris M, Singh A, Li L, Reddy R Adv Exp Med Biol. 2012; 765:31-37.

PMID: 22879011 PMC: 6546107. DOI: 10.1007/978-1-4614-4989-8_5.